Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
863 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
5 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
6 Recruiting Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Gefitinib;   Drug: Tremelimumab
7 Unknown  Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis
Condition: Carcinoma, Non Small Cell Lung
Intervention: Procedure: CT-scan, PET-scan
8 Recruiting Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Metastatic;   Non-small Cell Lung Cancer Recurrent
Intervention: Drug: MLN8237 and Erlotinib
9 Not yet recruiting A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC
Conditions: Non-small Cell Lung Cancer Metastatic;   Targetable Oncogenes (EGFR, ALK, ROS1)
Intervention: Radiation: SBRT with protons or photons
10 Recruiting Evaluate the Mediators of Sensitivity and Resistance to Nivolumab in Patients With Advanced NSCLCs
Condition: Advanced Stage Non-small Cell Lung Cancer
Intervention: Drug: nivolumab
11 Recruiting LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: docetaxel;   Drug: placebo;   Drug: nintedanib
12 Recruiting Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer;   Anemia;   Cancer;   Lung Cancer
Interventions: Drug: darbepoetin alfa 500 mcg Q3W;   Drug: placebo
13 Unknown  Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: pegylated endostatin and Paclitaxel-Carboplatin;   Drug: Placebo and Paclitaxel-Carboplatin
14 Unknown  Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Erlotinib;   Drug: Vinorelbine and Carboplatin
15 Recruiting Efficacy and Safety Study of BIBW 2992 to Treat Lung Cancer Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Afatinib (BIBW 2992)
16 Recruiting Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Tarceva;   Radiation: Radiotherapy
17 Recruiting A Study of RO5424802 in Patients With Non-Small Cell Lung Cancer Who Have ALK Mutation and Failed Crizotinib Treatment
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: RO5452802;   Drug: erlotinib [Tarceva]
18 Not yet recruiting Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection
Conditions: Non-small Cell Lung Cancer Stage Ⅱ;   Non-small Cell Lung Cancer Stage ⅢA
Interventions: Drug: S1 capsule;   Drug: Vinorelbine
19 Recruiting An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBF 1120;   Drug: Vinorelbine
20 Recruiting Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)
Conditions: Non-Small Cell Lung Cancer;   Brain Metastases;   EGFR Gene Mutation
Interventions: Drug: Gefitinib;   Radiation: WBRT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years